Author

D. Krunic

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 4 Approach:experimental assay· 4 Assay:bulk RNA-seq· 3 Organism:human· 3 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Narayanan· 2 shared B. Steffl· 2 shared C. Schmidt· 2 shared F. Bestvater· 2 shared J. Taranda· 2 shared S. Turcan· 2 shared A. A. Martija· 1 shared A. Abdollahi· 1 shared

Activity by Year

2021-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Narayanan

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Ultra-High Dose Rate Helium Ion Beams: Minimizing Brain Tissue Damage while Preserving Tumor Control

I. Dokic, M. Moustafa, T. Tessonnier, S. Meister, F. Ciamarone, M. Akbarpour, D. Krunic, T. Haberer, J. Debus, A. Mairani, A. Abdollahi

This study compares ultra-high-dose rate helium ion radiotherapy (FLASH) with standard dose rate (SDR) in mice, showing FLASH reduces brain injury and neuroinflammation while maintaining tumor control.

bioRxiv · Jun 13, 2024 · PreprintCell Biology

EMP3 sustains oncogenic EGFR/CDK2 signaling by restricting receptor degradation in glioblastoma

A. A. Martija, A. Krauss, N. Baechle, L. Doth, A. Christians, D. Krunic, M. Schneider, D. Helm, R. Will, C. Hartmann, C. Herold-Mende, A. von Deimling, S. Pusch

This study identifies EMP3 as a regulator of EGFR/CDK2 signaling in glioblastoma by stabilizing EGFR and promoting its oncogenic activity.

bioRxiv · May 6, 2023Cancer Biology

TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing

E. Demirdizen, R. Al-Ali, A. Narayanan, X. Sun, J. P. Varga, B. Steffl, M. Brom, D. Krunic, C. Schmidt, G. Schmidt, F. Bestvater, J. Taranda, S. Turcan

This study identifies TRIM67 as an oncogene in oligodendrogliomas that promotes cell motility, tumor growth, and membrane blebbing through Rho GTPase/ROCK signaling.

bioRxiv · Nov 5, 2021Cancer Biology

MEOX2 homeobox gene promotes growth of malignant gliomas

S. Turcan, A. Schönrock, E. Heinzelmann, B. Steffl, A. Narayanan, D. Krunic, M. Bähr, J.-W. Park, C. Schmidt, K. Ozduman, N. M. Pamir, W. Wick, F. Bestvater, D. Weichenhan, C. Plass, , M. Mall

This study identifies MEOX2 as an oncogenic transcription factor in glioblastoma, showing it promotes tumor growth through ERK signaling and cooperates with p53 and PTEN loss.

bioRxiv · Aug 24, 2021Cancer Biology